SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy
Press release – Oslo, Norway, December 1, 2023: Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces that new evidence from routine clinical practice in the Veterans Affairs (VA) healthcare system was presented at the 24[th] Annual Society of Urologic Oncology (SUO) meeting demonstrating a significantly reduced risk of tumor recurrence (33%) in non-muscle invasive bladder cancer (NMIBC) patients who received Blue Light Cystoscopy (BLC[®]) compared to patients who only underwent standard White Light Cystoscopy (WLC).The abstract and Poster entitled “Comparing white light versus